Susquehanna International Group
AMPE

Susquehanna International Group’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Susquehanna International Group’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-19,580
Closed -$40.1K – 13873
2023
Q4 		$40.1K Buy
+19,580
New +$50.7K ﹤0.01% 11796
2023
Q1 		– Sell
-3,330
Closed -$18.7K – 14250
2022
Q4 		$15K Buy
3,330
+2,943
+760% +$19K ﹤0.01% 11847
2022
Q3 		$7K Sell
387
-351
-48% -$12.3K ﹤0.01% 12851
2022
Q2 		$37K Buy
738
+686
+1,319% +$51.1K ﹤0.01% 12139
2022
Q1 		$7K Sell
52
-200
-79% -$29.2K ﹤0.01% 12800
2021
Q4 		$43K Sell
252
-549
-69% -$205K ﹤0.01% 12625
2021
Q3 		$399K Sell
801
-1,131
-59% -$524K ﹤0.01% 9951
2021
Q2 		$968K Sell
1,932
-1,478
-43% -$794K ﹤0.01% 7867
2021
Q1 		$1.73M Buy
3,410
+1,465
+75% +$756K ﹤0.01% 6273
2020
Q4 		$928K Buy
1,945
+447
+30% +$147K ﹤0.01% 6890
2020
Q3 		$430K Buy
1,498
+605
+68% +$150K ﹤0.01% 7989
2020
Q2 		$171K Buy
893
+244
+38% +$40.6K ﹤0.01% 9165
2020
Q1 		$81K Sell
649
-3,346
-84% -$606K ﹤0.01% 9447
2019
Q4 		$699K Buy
3,995
+2,673
+202% +$345K ﹤0.01% 6270
2019
Q3 		$199K Buy
+1,322
New +$176K ﹤0.01% 9097
2018
Q2 		– Sell
-714
Closed -$534K – 10689
2018
Q1 		$728K Buy
714
+555
+349% +$465K ﹤0.01% 5870
2017
Q4 		$194K Buy
+159
New +$74.8K ﹤0.01% 8305
2017
Q3 		– Sell
-249
Closed -$39K – 9887
2017
Q2 		$39K Sell
249
-2,265
-90% -$458K ﹤0.01% 8936
2017
Q1 		$603K Sell
2,514
-5,434
-68% -$1.46M ﹤0.01% 6148
2016
Q4 		$2.15M Buy
+7,948
New +$1.89M ﹤0.01% 3919
2016
Q3 		– Sell
-248
Closed -$96K – 9253
2016
Q2 		$96K Sell
248
-689
-74% -$753K ﹤0.01% 8046
2016
Q1 		$632K Sell
937
-769
-45% -$518K ﹤0.01% 5977
2015
Q4 		$1.79M Buy
1,706
+636
+59% +$629K ﹤0.01% 4262
2015
Q3 		$927K Sell
1,070
-794
-43% -$664K ﹤0.01% 5919
2015
Q2 		$1.32M Buy
1,864
+1,089
+141% +$1.16M ﹤0.01% 5585
2015
Q1 		$1.75M Buy
775
+480
+163% +$818K ﹤0.01% 4571
2014
Q4 		$303K Sell
295
-416
-59% -$445K ﹤0.01% 8119
2014
Q3 		$753K Sell
711
-101
-12% -$170K ﹤0.01% 6477
2014
Q2 		$2.03M Buy
812
+129
+19% +$263K ﹤0.01% 4628
2014
Q1 		$1.3M Buy
683
+389
+132% +$920K ﹤0.01% 5053
2013
Q4 		$630K Sell
294
-1,119
-79% -$2.65M ﹤0.01% 6336
2013
Q3 		$3.18M Buy
+1,413
New +$2.73M ﹤0.01% 3392

Other funds holding AMPE

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
GIA
GHP Investment Advisors Denver, Colorado $2.72B AUM 27.58% 1-Year Est. Return
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Susquehanna International Group's AMPE Position: Q1 2024 in Review

Susquehanna International Group sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q1 2024, closing a stake of 19,580 shares — an estimated $40.1K sold.

Susquehanna International Group first reported a position in AMPE in Q3 2013 and held it in 32 quarters. The position peaked at $3.18M in Q3 2013. 28 funds tracked by Wall St. Rank hold AMPE as of Q1 2024.

  • Susquehanna International Group reported no remaining Ampio Pharmaceuticals Inc. position as of Q1 2024 after selling out during the quarter.
  • Susquehanna International Group sold 19,580 Ampio Pharmaceuticals Inc. shares in Q1 2024, an estimated $40.1K.
  • Susquehanna International Group first reported a position in Ampio Pharmaceuticals Inc. in Q3 2013 and held it in 32 quarters.
  • Susquehanna International Group's Ampio Pharmaceuticals Inc. position peaked at $3.18M in Q3 2013.
  • 28 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q1 2024.

Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.